Photo taken from onlinelibrary.wiley.com
Apr 26, 2024, 06:33
Emma Groarke on Ruxolitinib Study for Refractory T-LGL Leukemia from France
Emma Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on X/Twitter:
“Nice paper from France in British Journal of Haematology on a series of relapsed/refractory T- Large granular lymphocytic leukemia (LGL) patients treated with Ruxolitinib.
Some response observed in 86% though complete response in 14%.
A potentially good option for patients going forward.”
Additional information.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 04:41
Oct 23, 2024, 04:34
Oct 23, 2024, 04:16
Oct 23, 2024, 04:04
Oct 23, 2024, 03:50
Oct 23, 2024, 03:08
Oct 23, 2024, 02:59
Oct 23, 2024, 02:53
Oct 23, 2024, 02:46